Login to Your Account

Teva's Austedo for Huntington's chorea wins FDA approval

By Michael Fitzhugh
Staff Writer

Tuesday, April 4, 2017

Ten months after an FDA CRL set back efforts by Teva Pharmaceutical Industries Ltd. to gain its first approval for Austedo, an agency review has finally led to approval for the orphan-designated drug.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription